Pharmacologic evaluation of Edan.
D000700:Analgesics / Q000494:pharmacology*; D000779:Anesthetics, Local / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001001:Anura; D001693:Biological Transport, Active; D002462:Cell Membrane / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002986:Clinical Trials as Topic; D004048:Diethylamines / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D006168:Guinea Pigs; D007928:Lethal Dose 50; D051379:Mice; D011343:Procaine / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology*; D012964:Sodium / Q000378:metabolism; D012980:Sodium Salicylate / Q000494:pharmacology
D000700:Analgesics; D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D004048:Diethylamines; D012459:Salicylates; D011343:Procaine; D012964:Sodium; D012980:Sodium Salicylate